重症急性胰腺炎C-反应蛋白、降钙素原、APACHE-Ⅱ评分与并发细菌感染的相关性研究

何海旺, 张泓. 重症急性胰腺炎C-反应蛋白、降钙素原、APACHE-Ⅱ评分与并发细菌感染的相关性研究[J]. 临床急诊杂志, 2019, 20(9): 701-705. doi: 10.13201/j.issn.1009-5918.2019.09.009
引用本文: 何海旺, 张泓. 重症急性胰腺炎C-反应蛋白、降钙素原、APACHE-Ⅱ评分与并发细菌感染的相关性研究[J]. 临床急诊杂志, 2019, 20(9): 701-705. doi: 10.13201/j.issn.1009-5918.2019.09.009
HE Haiwang, ZHANG Hong. The changes of C-reactive protein, procalcitonin and APACHE-Ⅱ score and their relationships with complicated bacterial infection in patients with severe acute pancreatitis[J]. J Clin Emerg, 2019, 20(9): 701-705. doi: 10.13201/j.issn.1009-5918.2019.09.009
Citation: HE Haiwang, ZHANG Hong. The changes of C-reactive protein, procalcitonin and APACHE-Ⅱ score and their relationships with complicated bacterial infection in patients with severe acute pancreatitis[J]. J Clin Emerg, 2019, 20(9): 701-705. doi: 10.13201/j.issn.1009-5918.2019.09.009

重症急性胰腺炎C-反应蛋白、降钙素原、APACHE-Ⅱ评分与并发细菌感染的相关性研究

  • 基金项目:

    安徽省科技攻关计划项目(No:1301042206)

详细信息
    通讯作者: 张泓,E-mail:zhanghong20070703@163.com
  • 中图分类号: R657.51

The changes of C-reactive protein, procalcitonin and APACHE-Ⅱ score and their relationships with complicated bacterial infection in patients with severe acute pancreatitis

More Information
  • 目的: 探讨重症急性胰腺炎(SAP)患者C-反应蛋白(CRP)、降钙素原(PCT)、APACHE-Ⅱ评分变化与并发细菌感染的关系。方法: 按照纳入排除标准回顾性收集2017-01-2018-05期间我院急诊内科及急诊ICU收治的56例SAP患者,根据患者住院病程中是否合并细菌感染,分为非感染组(21例)和感染组(35例),分析患者CRP、PCT、APACHE-Ⅱ评分变化,并探讨三者的变化与并发细菌感染的关系。结果: 非感染组和感染组在入院第1天及第3天CRP、PCT、APACHE-Ⅱ评分方面差异无统计学意义,非感染组和感染组在入院1周时CRP、PCT、APACHE-Ⅱ评分及其差值方面差异有统计学意义,ROC曲线结果显示,在评价SAP合并细菌感染的敏感度、特异度、曲线下面积(AUC)方面,CRP差值以-12.02 mg/L为临界值时分别为65.71%、85.71%、0.780,PCT差值以0.21μg/L为临界值时分别为80.00%、71.43%、0.737,APACHE-Ⅱ评分差值以-3为临界值时分别为57.14%、95.24%、0.773,三者联合时分别为68.57%、90.48%、0.864,三者联合与三者单独相比时差异无统计学意义(P>0.05),三者之间差异均无统计学意义(P>0.05)。结论: SAP患者CRP、PCT、及APACHE-Ⅱ评分变化与其并发细菌感染相关,监测三者水平变化可为SAP患者并发细菌感染提供早期理论支持,但三者联合时诊断效能未见明显改善。
  • 加载中
  • [1]

    Li J,Chen J,Tang W.The consensus of integrative diagnosis and treatment of acute pancreatitis-2017[J].J Evid Based Med,2019,12(1):76-88.

    [2]

    Lagoo JY,D'Souza MC,Kartha A,et al.Role of Ulinastatin,a trypsin inhibitor,in severe acute pancreatitis in critical care setting:A retrospective analysis[J].J Crit Care,2018,45(6):27-32.

    [3]

    Yang R,Tenhunen J,Tonnessen TI.HMGB1 and Histones Play a Significant Role in Inducing Systemic Inflammation and Multiple Organ Dysfunctions in Severe Acute Pancreatitis[J].Int J Inflam,2017,21(2):1-6.

    [4]

    Gao N,Yan C,Zhang G.Changes of Serum Procalcitonin(PCT),C-Reactive Protein(CRP),Interleukin-17(IL-17),Interleukin-6(IL-6),High Mobility Group Protein-B1(HMGB1) and D-Dimer in Patients with Severe Acute Pancreatitis Treated with Continuous Renal Replacement Therapy(CRRT) and Its Clinical Significance[J].Med Sci Monit,2018,24:5881-5886.

    [5]

    Kumar S,Jalan A,Patowary BN,et al.To Access the Role of Serum Procalcitonin in Predicting the Severity of Acute Pancreatitis[J].Kathmandu Univ Med J(KUMJ),2017,15(57):19-24.

    [6]

    Bezmarevic M,Mirkovic D,Mickovic S,et al.Correlation between procalcitonin and intra-abdominal pressure and their role in prediction of the severity of acute pancreatitis[J].Pancreatology,2012,12(4):337-343.

    [7]

    Surag KR,Vishnu VH,Muniyappa S,et al.Accuracy and Predictability of PANC-3 Scoring System over APACHE Ⅱ in Acute Pancreatitis:A Prospective Study[J].J Clin Diagn Res,2017,11(2):PC10-PC13.

    [8]

    Harshit Kumar A,Singh Griwan M.A comparison of APACHE Ⅱ,BISAP,Ranson's score and modified CTSI in predicting the severity of acute pancreatitis based on the 2012 revised Atlanta Classification[J].Gastroenterol Rep(Oxf),2018,6(2):127-131.

    [9]

    Banks PA,Bollen TL,Dervenis C,et al.Classification of acute pancreatitis-2012:revision of the Atlanta classification and definitions by international consensus[J].Gut,2013,62(1):102-111.

    [10]

    Leppaniemi A.2019 WSES guidelines for the management of severe acute pancreatitis[J].World J Emerg Surg,2019,14:27.

    [11]

    Zorniak M,Beyer G,Mayerle J.Risk Stratification and Early Conservative Treatment of Acute Pancreatitis[J].Visc Med,2019,35(2):82-89.

    [12]

    Yang N.The effect of thymosin alpha1 for prevention of infection in patients with severe acute pancreatitis[J].Expert Opin Biol Ther,2018,18(Suppl 1):53-60.

    [13]

    Stirling AD.The predictive value of C-reactive protein(CRP) in acute pancreatitis-is interval change in CRP an additional indicator of severity?[J].HPB(Oxford),2017,19(10):874-880.

    [14]

    Vasseur P.High plasma levels of the pro-inflammatory cytokine IL-22 and the anti-inflammatory cytokines IL-10 and IL-1ra in acute pancreatitis[J].Pancreatology,2014,14(6):465-469.

    [15]

    Meyer A.Severe acute pancreatitis:a possible role of intramyocardial cytokine production[J].JOP,2014,15(3):237-242.

    [16]

    Dias BH.Procalcitonin Strip Test as an Independent Predictor in Acute Pancreatitis[J].Indian J Surg,2015,77(Suppl 3):1012-1017.

    [17]

    Soyalp M.Investigation of procalcitonin,IL-6,oxidative stress index(OSI) plasma and tissue levels in experimental mild and severe pancreatitis in rats[J].Bratisl Lek Listy,2017,118(3):137-141.

  • 加载中
计量
  • 文章访问数:  204
  • PDF下载数:  141
  • 施引文献:  0
出版历程
收稿日期:  2019-08-12

目录